DnB Asset Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.17M | Sell |
7,564
-472
| -6% | -$136K | 0.01% | 555 |
|
|
2025
Q1 | $2.48M | Buy |
8,036
+438
| +6% | +$135K | 0.01% | 531 |
|
|
2024
Q4 | $2.68M | Sell |
7,598
-207
| -3% | -$73K | 0.01% | 528 |
|
|
2024
Q3 | $2.8M | Buy |
7,805
+5
| +0.1% | +$1.79K | 0.01% | 515 |
|
|
2024
Q2 | $2.48M | Buy |
7,800
+1,208
| +18% | +$385K | 0.01% | 507 |
|
|
2024
Q1 | $1.51M | Sell |
6,592
-3,786
| -36% | -$870K | 0.01% | 588 |
|
|
2023
Q4 | $2.28M | Sell |
10,378
-4,409
| -30% | -$969K | 0.01% | 522 |
|
|
2023
Q3 | $3.34M | Buy |
+14,787
| New | +$3.34M | 0.02% | 439 |
|
|
2020
Q3 | – | Sell |
-93,555
| Closed | -$11.3M | – | 620 |
|
|
2020
Q2 | $11.3M | Sell |
93,555
-43,135
| -32% | -$5.22M | 0.13% | 126 |
|
|
2020
Q1 | $13M | Buy |
136,690
+17,954
| +15% | +$1.7M | 0.19% | 104 |
|
|
2019
Q4 | $10.5M | Buy |
+118,736
| New | +$10.5M | 0.1% | 159 |
|
|
2019
Q2 | – | Sell |
-25,243
| Closed | -$2.96M | – | 642 |
|
|
2019
Q1 | $2.96M | Buy |
25,243
+9,487
| +60% | +$1.11M | 0.03% | 321 |
|
|
2018
Q4 | $1.72M | Buy |
+15,756
| New | +$1.72M | 0.02% | 420 |
|